New Targetable Oncogenes in Non–Small-Cell Lung CancerGeoffrey R. Oxnard, Pasi A. Jänne, Adam Binder|Journal of Clinical Oncology|2013Cited by 298
Interim analysis of LimiTec, a prospective trial of limited-duration teclistamab for relapsed/refractory multiple myelomaBeatrice M. Razzo, Alfred L. Garfall, Wei‐Ting Hwang et al.|Blood|2025Cited by 6